A new drug helps men with advanced prostate cancer live longer, even after they have not been helped by other treatments, researchers reported Wednesday. The drug, called enzalutamide, is a pill that tackles prostate tumors from several different directions, interfering with molecular pathways that help them grow. It does not cause the nausea, hair loss and other side effects often associated with chemotherapy.
The study found that men taking enzalutamide lived 37 percent longer on average. That is the good news.